Divi Resorts is bringing back its popular Kids Stay & Eat Free program for a limited time! On all-inclusive stays, kids 12 ...

Divi's Labs makes active pharmaceutical ingredients for Entresto for Novartis, which contributes nearly 8% to Hyderabad-based ...

Brokerage firm IIFL has warned that due to this development, Divi's Laboratories' annual Earnings Before Interest, Tax, ...

Entresto is considered a cornerstone of Divi’s innovator-driven custom synthesis portfolio, contributing close to 40 percent ...

Stock recommendations today include HCLTech, Ola Electric, Kalyan Jewellers, and Sun Pharma as analysts review June quarter ...

UTI MF sold aggressively in Infosys and in modest quantities in Reliance and Bharti Airtel. The fund’s top 5 stock picks for ...

AGNC Investment invests solely in mortgage-backed securities (MBS) protected from credit risk by government agencies like ...

Under the new water policy of DJB, each operator will be responsible for water supply, sewerage network management, billing, repairs, and reducing Non-Revenue Water (NRW), an official stated.

Anthem Biosciences’ IPO puts the spotlight on India’s contract drug manufacturing sector, as investor appetite swells and global firms diversify away from China.

Anthem ticks all the boxes. But with lofty valuations and limited margin headroom, analysts warn the IPO may not deliver ...

Anthem Biosciences is a leading player in the fast growing CRDMO (Contract Research, Development and Manufacturing ...

Anthem Biosciences IPO on Day 2 with moderate success, price band ₹540-570, 35% reserved for retail investors.